[1] Eric Jonasch, Cheryl Lyn Walker, W Kimryn Rathmell. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2021 Apr;17(4):245-261. doi: 10.1038/s41581-020-00359-2. Epub 2020 Nov 3.
[2] W Marston Linehan , Christopher J Ricketts. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol. 2019 Sep;16(9):539-552. doi: 10.1038/s41585-019-0211-5. Epub 2019 Jul 5.
[3] Jianping Zhao, Eduardo Eyzaguirre. Clear Cell Papillary Renal Cell Carcinoma.Arch Pathol Lab Med. 2019 Sep;143(9):1154-1158. doi: 10.5858/arpa.2018-0121-RS. Epub 2019 Jan 23.
[4] Qingyang Liu , Myung H Kim , Leon Friesen, Chang H Kim. BATF regulates innate lymphoid cell hematopoiesis and homeostasis. Sci Immunol. 2020 Dec 4;5(54):eaaz8154. doi: 10.1126/sciimmunol.aaz8154.
[5] Melissa M Wolf , W Kimryn Rathmell et al. Modeling clear cell renal cell carcinoma and therapeutic implications. Oncogene. 2020 Apr;39(17):3413-3426. doi: 10.1038/s41388-020-1234-3. Epub 2020 Mar 2.
[6] Yongyao Fu, Byunghee Koh , Makoto Kuwahara , Benjamin J Ulrich et al. BATF-Interacting Proteins Dictate Specificity in Th Subset Activity. J Immunol. 2019 Oct 1;203(7):1989-1998. doi: 10.4049/jimmunol.1900128. Epub 2019 Aug 26.
[7] Hao P, Kang B, Li Y, Hao W, Ma F.UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.Mol Med Rep. 2019 Aug;20(2):1212-1220. doi: 10.3892/mmr.2019.10322. Epub 2019 Jun 3.PMID: 31173226 Free PMC article.
[8] Liu H, Li X, Duan Y, Xie JB, Piao XL.Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.J Ethnopharmacol. 2021 May 10;271:113907. doi: 10.1016/j.jep.2021.113907. Epub 2021 Feb 6.PMID: 33556477
[9] Luongo F, Colonna F, Calapà F, Vitale S, Fiori ME, De Maria R.PTEN Tumor-Suppressor: The Dam of Stemness in Cancer.Cancers (Basel). 2019 Jul 30;11(8):1076. doi: 10.3390/cancers11081076.
PMID: 31366089 Free PMC article. Review.
[10] Mu L, Guan B, Tian J, Li X et al. MicroRNA-218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2. Oncol Rep. 2020 Nov;44(5):1961-1970. doi: 10.3892/or.2020.7759. Epub 2020 Sep 8. PMID: 32901879 Free PMC article.
[11] Jun Wei , Lingyun Long , Wenting Zheng et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019 Dec;576(7787):471-476.doi: 10.1038/s41586-019-1821-z. Epub 2019 Dec 11.
[12] Qianqian Liu, Qinfang Ou, Lei Shen et al. BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in Mycobacterium tuberculosis Infection. Front Immunol. 2019 Oct 15;10:2430. doi: 10.3389/fimmu.2019.02430. eCollection 2019.
[13] Yu Feng, Liangbin Pan, Biao Zhang et al. BATF acts as an oncogene in non-small cell lung cancer.Oncol Lett. 2020 Jan;19(1):205-210. doi: 10.3892/ol.2019.11075. Epub 2019 Nov 11.
[14] Ljubov Balabko , Katerina Andreev , Nadine Burmann et al. Increased expression of the Th17-IL-6R/ pST AT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung.Clinical Trial Sci Rep. 2014 Dec 10;4:7396. doi: 10.1038/srep07396.
[15] Hao Huang , Jinming Fu et al. Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma.Front Oncol. 2021 Jun 11;11:629860. doi: 10.3389/fonc.2021.629860. eCollection 2021.
[16] Zhenxia Zhang et al.Calycosin inhibits breast cancer cell migration and invasion by suppressing EMT via BATF /TGF-β1Aging. (Albany NY). 2021 Jun 7;13(12):16009-16023. doi: 10.18632/aging.203093. Epub 2021 Jun 7.
[17] Li H, Dan C, Gong X, Zeng W et al. Sorghumol triterpene inhibits the growth of circulating renal cancer cells by promoting cell apoptosis, G2/M cell cycle arrest and downregulating m-TOR/PI3K/AKT signalling pathway.J BUON. 2019 Jan-Feb;24(1):310-314.PMID: 30941986
[18] Antonios N Gargalionis, Eleni Sarlani et al. Polycystin-1 induces activation of the PI3K/AKT/mTOR pathway and promotes angiogenesis in renal cell carcinoma.Cancer Lett. 2020 Oct 1;489:135-143. doi: 10.1016/j.canlet.2020.06.016. Epub 2020 Jun 16.
[19] Xueting Ye , Jian-Wei Ruan et al.PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth in vitro and in vivo. Aging (Albany NY). 2020 May 18;12(10):9489-9499. doi: 10.18632/aging.103221. Epub 2020 May 18.
[20] Demin Fan , Qiang Liu et al .Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma.PeerJ. 2020 Jun 1;8:e9261. doi: 10.7717/peerj.9261. eCollection 2020.
[21] H Chen, D Zhu et al. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Clin Transl Oncol. 2019 Jul;21(7):939-949. doi: 10.1007/s12094-018-02012-8. Epub 2019 Jan 3.